Atrial Fibrillation Clinical Trials in Oklahoma City, Oklahoma

3 studies are recruiting for atrial fibrillation in Oklahoma City, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

    REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in parti…

    Stage
    Phase 3
    Ages
    22 to 85
    Site
    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
    Locations
    93 in total
    Run by
    Johns Hopkins University

    See if you can join NCT05836987 on ClinicalTrials.gov

  2. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    OU Medical Center, Oklahoma City, Oklahoma
    Locations
    187 in total
    Run by
    Yale University

    See if you can join NCT03907046 on ClinicalTrials.gov

  3. Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

    The study will investigate the effect of Dapagliflozin on atrial fibrillation (AF) burden. AF burden will be defined as the percent of time spent in AF over a 2-week period, assessed by noninvasive continuous heart rhythm monitoring at baseline and at 3 months, quality of life (QOL) and validated e…

    Stage
    Phase 3
    Ages
    18 to 85
    Site
    University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
    Run by
    University of Oklahoma

    See if you can join NCT05174052 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.